President Donald Trump plans to nominate Landon Heid, who served on the staff of the House of Representatives' Select ...

WuXi AppTec Co. and WuXi Biologics Cayman Inc. said they see a brighter 2025 for the Chinese biotech and drug companies after the US Biosecure legislation that threatened to cut them out from ...

MSD has expanded its presence in Ireland with an agreement to buy a vaccine manufacturing facility from Chinese biotech WuXi Biologics for around €500 million (around $520 million). The plant in ...

Ranked among the top 1% of companies assessed in the pharmaceutical industry <li /> Recognized as a leader in Green CRDMO, driving innova ...

WuXi AppTec is parting ways with its U.S. medical device testing business, selling its two stateside locations to the Ohio-based regulatory consulting firm NAMSA. The deal includes facilities in ...

The U.S. tariffs on China include a broad 10% levy on imported goods. China’s response was more targeted, with 15% tariffs on ...

It is well known that WuXi entities have become dangerously entwined with American biotech. BGI Group's genomic data collection and ties to the Chinese military have alarmed national security ...

A PAT roadmap should address data analysis, aggregation, visualization, and the smart utility of those data for greater process understanding.

SHANGHAI, Jan. 12, 2025 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life sciences ...

STA Pharmaceutical Hong Kong Investment, the shareholder of WUXI XDC (02268.HK) 0.000 (0.000%) Short selling $1.70M; Ratio 2.675% , placed 37.8 million shares of the company at $3 ...